146 related articles for article (PubMed ID: 38597655)
1. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.
Landry ML; Hassan S; Rottmann BG; Pesak SJ; Ordazzo M; Skrzyniarz M; Deponte S; Peaper DR
J Clin Microbiol; 2024 May; 62(5):e0013924. PubMed ID: 38597655
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the rapid Quidel Sofia Lyme fluorescent immunoassay as a first-tier test in a modified 2-tier testing algorithm for Lyme disease: A comparison with the Zeus ELISA Borrelia VlsE1/pepC10 lgG/IgM assay followed by the Zeus monovalent IgM/IgG confirmatory assay.
Lee-Lewandrowski E; Turbett S; Branda JA; Lewandrowski K
Am J Clin Pathol; 2023 Dec; 160(6):599-602. PubMed ID: 37549102
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays.
Sfeir MM; Meece JK; Theel ES; Granger D; Fritsche TR; Steere AC; Branda JA
J Clin Microbiol; 2022 May; 60(5):e0252821. PubMed ID: 35418241
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.
Pegalajar-Jurado A; Schriefer ME; Welch RJ; Couturier MR; MacKenzie T; Clark RJ; Ashton LV; Delorey MJ; Molins CR
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743307
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Novel Microarray Immunoblot Assay for Detection of IgM- and IgG-Class Antibodies to Borrelia burgdorferi.
Theel ES; Sorenson M; Granger D
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135227
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin.
Sabin AP; Scholze BP; Lovrich SD; Callister SM
Diagn Microbiol Infect Dis; 2023 Jan; 105(1):115837. PubMed ID: 36370542
[TBL] [Abstract][Full Text] [Related]
8. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
Davis IRC; McNeil SA; Allen W; MacKinnon-Cameron D; Lindsay LR; Bernat K; Dibernardo A; LeBlanc JJ; Hatchette TF
J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32321781
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.
Lipsett SC; Branda JA; Nigrovic LE
J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31413078
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot.
Lewandrowski EL; Branda JA; Lewandrowski K; Turbett S
Am J Clin Pathol; 2023 Jul; 160(1):58-61. PubMed ID: 36881650
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
[TBL] [Abstract][Full Text] [Related]
12. Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples.
Molins CR; Delorey MJ; Sexton C; Schriefer ME
J Clin Microbiol; 2016 Nov; 54(11):2726-2734. PubMed ID: 27558183
[TBL] [Abstract][Full Text] [Related]
13. Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context.
Can Commun Dis Rep; 2020 May; 46(5):125-131. PubMed ID: 32558809
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Testing for Lyme Disease.
Kobayashi T; Auwaerter PG
Infect Dis Clin North Am; 2022 Sep; 36(3):605-620. PubMed ID: 36116838
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of serologic tests for lyme disease.
Steere AC; McHugh G; Damle N; Sikand VK
Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of commercial screening tests and blot assays for the diagnosis of Lyme borreliosis.
Busson L; Reynders M; Van den Wijngaert S; Dahma H; Decolvenaer M; Vasseur L; Vandenberg O
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):246-51. PubMed ID: 22560168
[TBL] [Abstract][Full Text] [Related]
19. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
Dickeson DJ; Chen SC; Sintchenko VG
Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
[TBL] [Abstract][Full Text] [Related]
20. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease.
Engstrom SM; Shoop E; Johnson RC
J Clin Microbiol; 1995 Feb; 33(2):419-27. PubMed ID: 7714202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
